A novel approach to the treatment of early stage Hodgkin's disease with mitoxantrone-based regimen followed by involved field radiotherapy.

被引：0
|
作者：
O'Brien, TM
Anupama, R
Venugopal, P
Kaplan, EH
Gupta-Burt, S
Foster, GS
Gregory, SA
机构：
[1] Rush Canc Inst, Sect Hematol, Chicago, IL USA
[2] Rush Univ, Dept Radiat Oncol, Chicago, IL 60612 USA
[3] Rush Univ, Dept Diagnost Radiol & Nucl Med, Chicago, IL 60612 USA
[4] Rush N Shore Med Ctr, Skokie, IL USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4398
引用
收藏
页码：265B / 265B
页数：1
相关论文
共 50 条
  • [1] The efficacy of a novel mitoxantrone-based chemotherapeutic regimen in combination with involved-field radiotherapy for the treatment of early stage Hodgkin's lymphoma.
    Shammo, JM
    Tabesh, B
    Venugopal, P
    Gupta-Burt, S
    Gregory, SA
    BLOOD, 2002, 100 (11) : 298B - 298B
  • [2] A five drug regimen (VEBEP) followed by involved field radiotherapy in the treatment of Hodgkin's disease.
    De Renzo, A
    Pezzullo, L
    D'Arco, A
    Andriani, A
    Falzarano, G
    di Grazia, C
    Santoro, L
    Febbraro, A
    Parente, D
    Rotoli, B
    BLOOD, 1998, 92 (10) : 235B - 235B
  • [3] Early-stage Hodgkin's disease (ESHD) treated with radiotherapy involved field (IFRT) and chemotherapy
    Santoro, M.
    Scalzo, C.
    Pingitore, A.
    Squillace, R.
    Molica, S.
    Prantera, T.
    Cicero, G.
    Condemi, G.
    Pingitore, D.
    ANNALS OF ONCOLOGY, 2006, 17 : XI58 - XI58
  • [4] Early-stage Hodgkin's disease (ESHD) treated with involved field radiotherapy (IFRT) and chemotherapy
    Santoro, M.
    Falcone, S.
    Riccelli, R.
    Colosimo, A.
    Ianni, R.
    Pingitore, D.
    ANNALS OF ONCOLOGY, 2005, 16 : 151 - 151
  • [5] Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy
    Tormo, M
    Terol, MJ
    Marugán, I
    Solano, C
    Benet, I
    Garcia-Conde, J
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 137 - 142
  • [6] Novel chemoradiation regimen improves outlook in early-stage Hodgkin's disease
    不详
    ONCOLOGY-NEW YORK, 2002, 16 (02): : 151 - 151
  • [7] CEBOPP/VIML followed by radiotherapy for unfavorable early-stage or advanced-stage Hodgkin's disease.
    Nowrousian, MR
    Ernst, S
    Beling, C
    Fink, H
    Welt, A
    Schuette, J
    Moritz, T
    Flasshove, M
    Bojko, P
    Seeber, S
    Metz, KA
    Stuschke, M
    BLOOD, 2001, 98 (11) : 131A - 131A
  • [8] Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy
    Chronowski, GM
    Wilder, RB
    Tucker, SL
    Ha, CS
    Younes, A
    Fayad, L
    Rodriguez, MA
    Hagemeister, FB
    Barista, I
    Cox, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01): : 36 - 43
  • [9] Consolidating Involved Field Radiotherapy Prevents Early and Local Recurrences in Early Stage Hodgkin Lymphoma
    Baues, C.
    Goergen, H.
    Fuchs, M.
    Kobe, C.
    Dietlein, M.
    Rosenbrock, J.
    Celik, E.
    Eich, H. T. T.
    Kriz, J.
    Semrau, R.
    Borchmann, P.
    Engert, A.
    Marnitz, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S32 - S33
  • [10] Successful treatment of non-Hodgkin's lymphoma of the CNS with the BMPD chemotherapy protocol followed by radiotherapy.
    Thiel, E
    Korfel, A
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 409 - 409
12345